Literature DB >> 27000139

Moxifloxacin-Induced Visual Hallucinations: A Case Report and Review of the Literature.

Emily Higdon1,2, Jennifer D Twilla1,2, Christopher Sands1,3.   

Abstract

Fluoroquinolones are extensively used to treat a variety of common bacterial infections. Due to their extensive use in clinical practice, increases in neuropsychiatric events have been reported. We discuss the case of a young female who developed visual hallucinations after 2 doses of moxifloxacin. After discontinuation of the moxifloxacin, the patient's symptoms completely resolved. While one other case report exists with moxifloxacin, this case is unique in comparison. Our patient was a young female with no kidney dysfunction, no drug abuse history, absence of polypharmacy, and no previous psychological history that would have put her at an increased risk of drug-induced psychosis. Due to the prevalence of medication-induced hallucinations, it is imperative that clinicians are able to recognize offending medications in an effort to prevent misdiagnosis of a psychiatric illness.

Entities:  

Keywords:  fluoroquinolones; hallucinations; moxifloxacin

Mesh:

Substances:

Year:  2016        PMID: 27000139     DOI: 10.1177/0897190016637987

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  2 in total

1.  Moxifloxacin-induced acute psychosis: A case report with literature review.

Authors:  Faizan Mazhar; Shahzad Akram; Nafis Haider
Journal:  J Res Pharm Pract       Date:  2016 Oct-Dec

2.  Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System.

Authors:  Cristina Scavone; Annamaria Mascolo; Rosanna Ruggiero; Liberata Sportiello; Concetta Rafaniello; Liberato Berrino; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.